Australia Últimas notícias

Amaero (ASX:3DA) has postponed its proposed U.S. initial public offering after citing adverse market conditions.

Ethical wealth manager Australian Ethical Investment (ASX:AEF) has announced that Chair Steve Gibbs will retire from the board by June 30, 2027.

Treasury Secretary Scott Bessent announced the US and China have sealed a two-month extension to their trade truce as Xi Jinping landed in America for his first state visit in eleven years.

Nexsen (ASX:NXN) paused its StrepSure clinical trial for product enhancements, which the company expects will delay regulatory submission by one quarter.

An automated artificial intelligence software agent created by OpenAI breached an Australian federal government Medicare data portal.

Native Mineral Resources (ASX:NMR) has produced 283.3 ounces of gold doré weighing 8.81 kilograms from its processing circuit.

Maas Group (ASX:MGH) expects its electrical manufacturing division to be the main driver of company profit for fiscal 2027.

Vection Technologies (ASX:VR1) signed reciprocal, non-exclusive master reseller agreements with Xerox for an initial five-year term starting June 29.

Wendy Cutler, Senior Vice President at the Asia Society Policy Institute and former Acting Deputy US Trade Representative, discusses the outlook for US-China trade relations after US Treasury Secretary Scott Bessent announced that the two countries had agreed to a two-month extension of their trade truce. She speaks with Haidi Stroud-Watts on Bloomberg: The Asia Trade.

Daleep Singh, Vice Chair and Chief Global Economist at PGIM, discusses his outlook for the global economy, inflation and rates, as leaders of the world's two most powerful economies meet in Washington for a high level summit on trade and AI. He speaks with Haidi Stroud Watts on "Bloomberg: The Asia Trade".

Eric Zheng, President of AmCham Shanghai, discusses his expectations for Chinese President Xi and US President Trump's high level summit in Washington, and its potential implications for US businesses working operating in China. He speaks with Stephen Engle in Washington on "Bloomberg: The Asia Trade".

Ovarian cancer diagnostics company Cleo Diagnostics (ASX:COV) has commenced prototype development of a multi-biomarker blood test.